3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
79
Breast Neoplasms
7
Neoplasms
6
Prostate Adenocarcinoma
2
Polycystic Ovary Syndrome
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leiomyoma
2
Hodgkin Disease
2
Uveal Melanoma
1
Urogenital Neoplasms
1
Sleep Apnea, Obstructive
1
Skin Neoplasms
1
Recurrence
1
Prostatic Diseases
1
Premenopausal Breast Cancer
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
PSA Level Greater Than Two
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms, Glandular and Epithelial
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Metabolic Syndrome
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphatic Metastasis
1
Lower Urinary Tract Symptoms
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
Sunitinib
3
avelumab
2
Nutrition Assessment
2
Axitinib
2
spartalizumab
1
pembrolizumab
1
etelcalcetide hydrochloride
1
aldesleukin
1
Sorafenib
1
Resistance Training
1
Plasma Exchange
1
Interleukin-2
1
Adalimumab
1
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Kidney Diseases
×
Leuprolide
×
Clear all
No trials found.